The New York Post: Pfizer-BioNTech vaccine neutralizes Brazil COVID-19 variant, study shows

United States

The Pfizer coronavirus vaccine is able to neutralize a rapidly spreading virus variant from Brazil, according to a new laboratory study.

Researchers developed an engineered version of the COVID-19 mutation and found that blood samples taken from people who received the vaccine were able to neutralize the variant, according to the study published in the New England Journal of Medicine on Monday.